{"title":"Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence by alleviating oxidative damage and regulating intestinal metabolism.","authors":"Tongpeng Yue, Yinping Dong, Qidong Huo, Wenxuan Li, Xinyue Wang, Shiyi Zhang, Huirong Fan, Xin Wu, Xin He, Yu Zhao, Deguan Li","doi":"10.1016/j.jare.2024.07.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The intestine, frequently subjected to pelvic or abdominal radiotherapy, is particularly vulnerable to delayed effects of acute radiation exposure (DEARE) owing to its high radiation sensitivity. Radiation-induced intestinal senescence, a result of DEARE, profoundly affects the well-being and quality of life of radiotherapy patients. However, targeted pharmaceutical interventions for radiation-induced senescence are currently scarce. Our findings showcase that nicotinamide riboside(NR) effectively alleviates radiation-induced intestinal senescence, offering crucial implications for utilizing NR as a pharmacological agent to combat intestinal DEARE.</p><p><strong>Objectives: </strong>The aim of this study was to investigate the ability of NR to reduce radiation induced intestinal senescence and explore its related mechanisms.</p><p><strong>Methods: </strong>Male C57BL/6J mice were randomly divided into CON, IR, and IR + NR groups. The mice in the IR and IR + NR groups were subjected to a 6.0 Gy γ-ray total body exposure. After 8 weeks, the mice in the IR + NR group received NR via gavage at a dose of 400 mg/kg/d for 21 days. Then the mice were used for sample collection.</p><p><strong>Results: </strong>Our results demonstrate that NR can significantly mitigate radiation-induced intestinal senescence. Furthermore, our findings indicate that NR can mitigate oxidative damage, restore the normal function of intestinal stem cells, regulate the disruption of the intestinal symbiotic ecosystem and address metabolic abnormalities. In addition, the underlying mechanisms involve the activation of SIRT6, SIRT7 and the inhibition of the mTORC1 pathway by NR.</p><p><strong>Conclusion: </strong>In conclusion, our results reveal the substantial inhibitory effects of NR on radiation-induced intestinal senescence. These findings offer valuable insights into the potential therapeutic use of NR as a pharmacological agent for alleviating intestinal DEARE.</p>","PeriodicalId":94063,"journal":{"name":"Journal of advanced research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of advanced research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jare.2024.07.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The intestine, frequently subjected to pelvic or abdominal radiotherapy, is particularly vulnerable to delayed effects of acute radiation exposure (DEARE) owing to its high radiation sensitivity. Radiation-induced intestinal senescence, a result of DEARE, profoundly affects the well-being and quality of life of radiotherapy patients. However, targeted pharmaceutical interventions for radiation-induced senescence are currently scarce. Our findings showcase that nicotinamide riboside(NR) effectively alleviates radiation-induced intestinal senescence, offering crucial implications for utilizing NR as a pharmacological agent to combat intestinal DEARE.
Objectives: The aim of this study was to investigate the ability of NR to reduce radiation induced intestinal senescence and explore its related mechanisms.
Methods: Male C57BL/6J mice were randomly divided into CON, IR, and IR + NR groups. The mice in the IR and IR + NR groups were subjected to a 6.0 Gy γ-ray total body exposure. After 8 weeks, the mice in the IR + NR group received NR via gavage at a dose of 400 mg/kg/d for 21 days. Then the mice were used for sample collection.
Results: Our results demonstrate that NR can significantly mitigate radiation-induced intestinal senescence. Furthermore, our findings indicate that NR can mitigate oxidative damage, restore the normal function of intestinal stem cells, regulate the disruption of the intestinal symbiotic ecosystem and address metabolic abnormalities. In addition, the underlying mechanisms involve the activation of SIRT6, SIRT7 and the inhibition of the mTORC1 pathway by NR.
Conclusion: In conclusion, our results reveal the substantial inhibitory effects of NR on radiation-induced intestinal senescence. These findings offer valuable insights into the potential therapeutic use of NR as a pharmacological agent for alleviating intestinal DEARE.
导言:肠道经常接受盆腔或腹部放疗,由于其对辐射高度敏感,特别容易受到急性辐射照射的延迟效应(DEARE)的影响。辐射诱发的肠道衰老(DEARE)严重影响了放疗患者的健康和生活质量。然而,目前针对辐射诱导衰老的靶向药物干预还很少。我们的研究结果表明,烟酰胺核糖甙(NR)能有效缓解辐射诱导的肠道衰老,为利用 NR 作为药理制剂对抗肠道 DEARE 提供了重要意义:本研究旨在研究 NR 能否减轻辐射诱导的肠道衰老,并探索其相关机制:雄性 C57BL/6J 小鼠被随机分为 CON 组、IR 组和 IR + NR 组。IR组和IR + NR组的小鼠接受6.0 Gy γ射线全身照射。8 周后,IR + NR 组小鼠通过灌胃接受 NR,剂量为 400 mg/kg/d,持续 21 天。然后小鼠被用于样本采集:结果:我们的研究结果表明,NR 能显著缓解辐射诱导的肠道衰老。此外,我们的研究结果表明,NR 可以减轻氧化损伤,恢复肠道干细胞的正常功能,调节肠道共生生态系统的破坏,并解决代谢异常问题。此外,其潜在机制还包括 NR 激活 SIRT6、SIRT7 和抑制 mTORC1 通路:总之,我们的研究结果揭示了 NR 对辐射诱导的肠道衰老的实质性抑制作用。这些发现为将 NR 用作缓解肠道 DEARE 的潜在治疗药剂提供了宝贵的见解。